News

Learn about Syfovre, the first FDA approved treatment to slow vision loss from geographic atrophy, an advanced form of dry age-related macular degeneration.

The discovery led by BrightFocus-funded researcher, Thomas Karikari, PhD, will help expand the benefits of early diagnosis of dementia to traditionally underserved populations.

In recognition of Macular Degeneration Awareness Month, BrightFocus Foundation offers a variety of free educational resources to help individuals with macular degeneration and their loved ones navigate the disease.

A team of biochemists have identified new molecules in green tea that can destroy protein tangles in the brain linked to Alzheimer's and related brain diseases.

BrightFocus Foundation’s newly released research portfolios highlight the more than 250 active grants across our Alzheimer’s Disease Research, National Glaucoma Research, and Macular Degeneration Research programs in pursuit of discovering cures.

BrightFocus-supported clinical trial focused on older African-Americans finds that education and engagement around healthy aging may offer benefits that surpass exercise alone.